Ursodeoxycholic Acid (UDCA) Increases Lactate Clearance and Reduces Liver Injury by Inhibiting Farnesoid X Receptor (FXR) in Hemorrhagic Shock (HS)

Lu Wang,Xi Rui,Huai-Wu He,Xiang Zhou,Yun Long
DOI: https://doi.org/10.21203/rs.3.rs-797071/v1
2021-08-17
Abstract:Abstract Background: Hemorrhagic shock (HS) is one of the leading causes of death worldwide. Acute liver injury (ALI) is an important manifestation of HS. Farnesoid X receptor (FXR) plays an important role in the liver protection of bile acids. Therefore, we designed this experiment to study the effect of ursodeoxycholic acid (UDCA) on acute liver injury and its relationship with the FXR pathway in HS. Methods: In this study, eighteen adult male C57BL/6 mice were randomly divided into 3 groups of six mice per group applying a table of random numbers: sham group; HS group and HS + UDCA group. Six FXR (-/-) adult male C57BL mice were classified as FXR (-/-) + HS + UDCA group. As to model of HS, MAP of 40 ± 5 mmHg was maintained for 1 hour. As to UDCA intervention, UDCA (300mg/kg) was given nasally fed. Plasma alanine aminotransferase (ALT), aspartate aminotransferase (AST) were quantified with chromatographic quantitative kits according to the manufacturer’s instructions. Lactate concentration was determined by an automatic biochemical analyzer. The liver tissues were stained with hematoxylin and eosin (H&E) and scored histopathologically. Results: Plasma ALT, AST and lactate levels decreased significantly after treatment with UDCA under HS conditions. Pathological scores of liver tissues decreased significantly after treatment with UDCA under HS conditions. In the case of FXR (-/-), the influence of UDCA was inhibited. Conclusions: UDCA can reduce ALT, AST and lactate levels and alleviate liver injury during HS through the FXR pathway.
What problem does this paper attempt to address?